Clinical correlation between Programmed Cell Death Ligand One (PD L-1) Expression, Tumor Infiltrating Lymphocytes (TILs) and pathological response of locally advanced Human Epidermal Receptor (HER 2) & Triple Negative (TN) Breast Cancer (BC) Egyptian patients undergoing neoadjuvant Therapy